デフォルト表紙
市場調査レポート
商品コード
1555491

周産期感染症市場：感染症別、診断別、治療別、投与経路別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Perinatal Infections Market, By Infection, By Diagnosis, By Treatment, By Route of Administration, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
周産期感染症市場：感染症別、診断別、治療別、投与経路別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

レポートハイライト

周産期感染症市場規模は2023年に41億2,520万米ドルとなり、2024年から2032年にかけてCAGR 6.00%で拡大

周産期感染症市場-市場力学

周産期感染症の有病率の増加が市場成長を促進

周産期感染症の世界市場は、世界の出生前感染症の有病率の上昇により拡大しています。このような感染症は、母体も乳児も深刻な脅威にさらされており、予防、診断、治療方法の改善の必要性が浮き彫りになっています。妊娠中や分娩中はいつでも、周産期感染症によって母親の健康と胎児の健康が危険にさらされています。ヒト免疫不全ウイルス（HIV）、B型肝炎、梅毒、B群連鎖球菌（GBS）、クラミジアは、乳幼児に影響を及ぼす可能性のある一般的な病気です。これらの感染症は、早産、低出生体重児、新生児敗血症、先天異常、母体の罹患や死亡などの深刻な結果をもたらすことがあります。さらに、周産期感染症の発生頻度は、多くの原因によって上昇しています。未診断または未治療の感染症は、出生前ケアへのアクセスが不十分であることや、地域によってはヘルスケア資源が不足していることが原因です。出生前感染症は、薬物中毒、無防備な性行為、複数のパートナーの存在など、多くのハイリスク行動によって引き起こされる可能性があります。予防と教育の取り組みを通じてこれらの習慣に対処することが不可欠です。

周産期感染症市場-主な洞察

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約6.00%のCAGRで毎年成長すると推定されます。

感染セグメンテーションに基づくと、ヒト免疫不全ウイルスカテゴリーは2023年に最大の市場シェアを示すと予測されました。

診断セグメンテーションに基づくと、2023年には母体検査カテゴリーが主要セグメントでした。

治療セグメンテーションに基づくと、2023年には抗生物質カテゴリーが主要感染症でした。

投与経路のセグメンテーションに基づくと、2023年には非経口投与カテゴリーが主要セグメントでした。

地域別では、北米が2023年の主要収益源であった

周産期感染症市場-セグメンテーション分析：

世界の周産期感染症市場は、感染、診断、治療、投与経路、エンドユーザー、地域に基づいてセグメント化されます。

市場は診断に基づいて3つのカテゴリーに分けられる：母体検査、新生児検査、その他です。母体検査カテゴリーが市場を独占しています。胚や胎児はほとんど免疫を持っておらず、その結果、免疫を持ち、母親に依存しています。多くの病気は胎盤を通過した後に胎児に感染する可能性があります。妊婦が軽い病気を引き起こす細菌が、発育中の胎児や乳児に深刻なリスクをもたらす可能性があるため、妊婦はしばしば感染症を特定するための診断検査を受ける。

市場はエンドユーザーによって以下のカテゴリーに分けられる：病院、在宅医療、専門クリニック、その他です。病院が最も安全な出産場所と考えられていることから、病院カテゴリーが市場を独占しており、予測期間中もその優位性を維持するとみられます。National Academicsの報告によると、アメリカ人女性の98.4%は病院で出産しており、これは市場のかなりの部分を占めています。しかし、病院ではなく自宅や専門の分娩センターでの出産を選ぶ妊婦が増えているため、在宅医療や専門クリニックも予測期間中に急拡大する見込みです。

周産期感染症市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

予測期間中、北米が周産期感染症の世界市場で最大のシェアを占めると予想されています。早期発見・早期治療の価値を強調するため、同地域のヘルスケア業界は、出生前感染症に対する一般市民の認識を高めるべく尽力しています。北米では、スクリーニング・プログラム、予防接種キャンペーン、教育イニシアチブなどの政府施策が頻繁に実施されているため、周産期感染症市場は順調に成長しています。

さらに、周産期感染症市場は、医療技術革新と研究のための多額の支出を原動力として、アジア太平洋地域の予測期間中に世界で最も速い速度で拡大すると予測されています。アジア太平洋地域で行われた研究開発の結果、周産期感染症に対する先進的な診断ツールや治療アプローチが登場しています。アジア太平洋地域の周産期感染症市場は、同地域のヘルスケアインフラの拡大と母子の健康重視の高まりの結果、上昇を続けています。

周産期感染症市場-競合情勢：

Merck KGaA、Beckman Coulter Inc.、BIOMERIEUX、Bio-Rad Laboratories, Inc.、Danaher、Hologic Inc.など、周産期感染症市場の主要企業は、競争の激しい環境で優位に立つため、提携、M&A、製品イノベーションなどの戦略的取り組みに注力しています。これらの企業は、診断のブレークスルーを活用し、提供する製品を多様化することで、市場シェアを拡大し、顧客やヘルスケアプロバイダーの変化する需要を満たしたいと考えています。

目次

第1章 周産期感染症市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 周産期感染症の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 周産期感染症産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 周産期感染症市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 周産期感染症市場情勢

  • 周産期感染症市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 周産期感染症市場- 感染症別

  • 概要
    • 感染別セグメントシェア分析
    • サイトメガロウイルス感染症
    • エンテロウイルス感染症
    • 性器ヘルペス
    • 淋病
    • ヒト免疫不全ウイルス
    • その他

第8章 周産期感染症市場- 診断別

  • 概要
    • 診断別セグメントシェア分析
    • 母体検査
    • 新生児検査
    • その他

第9章 周産期感染症市場- 治療別

  • 概要
    • 治療別セグメントシェア分析
    • 抗生物質
    • 抗ウィルス薬
    • 抗レトロウイルス薬
    • その他

第10章 周産期感染症市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口
    • 非経口
    • その他

第11章 周産期感染症市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • ホームケア
    • 専門クリニック
    • その他

第12章 周産期感染症市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析- 周産期感染症業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Merck KgaA
    • Beckman Coulter Inc.
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc
    • Danaher
    • Hologic Inc.
    • Gilead Sciences, Inc.
    • Emcure Pharmaceuticals Limited.
    • Cipla Inc.
    • Hetero
    • Bausch Health Companies Inc.
    • Johnson &Johnson Private Limited
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd
    • Others

第14章 アナリストの全方位展望

目次
Product Code: ANV3568

REPORT HIGHLIGHT

Perinatal Infections Market size was valued at USD 4,125.2 Million in 2023, expanding at a CAGR of 6.00% from 2024 to 2032.

Infections that can spread from the mother to the child during pregnancy, labor, or the initial few hours after delivery are known as perinatal infections. Due to the limited ability of neonates, particularly those born preterm, to verbalize their symptoms, even slight deviations from the norm should be interpreted as an indication of bacterial disease. Pregnancy is a common time to see diseases such as listeria, bacterial vaginosis (BV), group B streptococcus (GBS), dermatitis, herpes, vaginal yeast infections, and the flu.

Perinatal Infections Market- Market Dynamics

Growing Prevalence of Perinatal Infections to Propel Market Growth

The global market for perinatal infections is expanding as a result of the rising prevalence of prenatal infections globally. The mother and the infant are both seriously threatened by these infections, which highlights the need for improved prevention, diagnostic, and treatment methods. Any time throughout pregnancy or during labor and delivery, a mother's health and the health of her unborn child are at danger due to perinatal infections. Human immunodeficiency virus (HIV), hepatitis B, syphilis, group B streptococcus (GBS), and chlamydia are common illnesses that can affect infants. Serious consequences include preterm birth, low birth weight, neonatal sepsis, congenital abnormalities, and mother morbidity and death can result from these infections. Furthermore, the frequency of perinatal infections is rising due to a number of causes. Undiagnosed or untreated infections are a result of inadequate access to prenatal care and scarce healthcare resources in some areas. Routine prenatal care visits are crucial to screen for and identify perinatal infections early on.Prenatal infections can result from a number of high-risk behaviors, including drug addiction, unprotected sexual activity, and having several partners. It is essential to address these habits through prevention and education initiatives.

Perinatal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.00% over the forecast period (2024-2032)

Based on infection segmentation, the human immunodeficiency virus category was predicted to show maximum market share in the year 2023

Based on diagnosis segmentation, the maternal test category was the leading segment in 2023

Based on treatment segmentation, the antibiotics category was the leading infection in 2023

Based on route of administration segmentation, the parenteral category was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Perinatal Infections Market- Segmentation Analysis:

The Global Perinatal Infections Market is segmented on the basis of Infection, Diagnosis, Treatment, Route of Administration, End User and Region.

The market is divided into three categories based on diagnosis: Maternal Test, Neonatal Test, and Others. The maternal test category dominates the market. The embryo and fetus have little to no immunity; as a result, they are immune and reliant on their mother. Many illnesses can infect the fetus after crossing the placenta. Pregnant women often undergo diagnostic testing to identify any infection since germs that cause mild illnesses in them might pose a serious risk to the developing fetus or infant.

The market is divided into the following categories based on end user: Hospitals, Homecare, Specialty Clinics, and Others. The hospitals category dominates the market and is likely to maintain its dominance during the forecast period, given that hospitals are thought to be the safest places to give birth. The National Academics reports that 98.4% of American women give birth in a hospital, which is a significant portion of the market. However, because more and more expectant mothers are choosing to give birth at home or in specialized birthing centers rather than in hospitals, homecare, and specialty clinics are also expected to see rapid expansion during the forecast period.

Perinatal Infections Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Perinatal Infections. In order to emphasize the value of early identification and treatment, the healthcare industry in the area has worked hard to increase public awareness of prenatal infections. The market for perinatal infections is growing favorably as a result of government measures in North America, which frequently include screening programs, immunization campaigns, and educational initiatives.

In addition, the Perinatal Infections market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific driven by large expenditures for medical innovation and research. Advanced diagnostic tools and treatment approaches for perinatal infections have emerged as a result of research and development conducted in the Asia Pacific. The Asia Pacific market for perinatal infections is continuing to rise as a result of the region's expanding healthcare infrastructure and growing emphasis on mother and child health.

Perinatal Infections Market- Competitive Landscape:

Key companies in the perinatal infections market such as Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, and Hologic Inc., among others, are concentrating on strategic efforts, including partnerships, mergers and acquisitions, and product innovations in order to obtain a competitive edge in a highly competitive landscape. These businesses hope to increase market share and satisfy customers' and healthcare providers' changing demands by capitalizing on diagnosis breakthroughs and diversifying their product offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERINATAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Merck KgaA
  • Beckman Coulter Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc
  • Danaher
  • Hologic Inc.
  • Gilead Sciences, Inc.
  • Emcure Pharmaceuticals Limited.
  • Cipla Inc.
  • Hetero
  • Bausch Health Companies Inc.
  • Johnson & Johnson Private Limited
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY INFECTION- MARKET ANALYSIS, 2019 - 2032

  • Cytomegalovirus Infection
  • Enterovirus Infection
  • Genital Herpes
  • Gonorrhoea
  • Human Immunodeficiency Virus
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Maternal Test
  • Neonatal Test
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Antibiotics
  • Antiviral
  • Antiretroviral
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Parenteral
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Perinatal Infections Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Perinatal Infections Market Snippet by Infection
    • 2.1.2. Perinatal Infections Market Snippet by Diagnosis
    • 2.1.3. Perinatal Infections Market Snippet by Treatment
    • 2.1.4. Perinatal Infections Market Snippet by Route of Administration
    • 2.1.5. Perinatal Infections Market Snippet by End User
    • 2.1.6. Perinatal Infections Market Snippet by Country
    • 2.1.7. Perinatal Infections Market Snippet by Region
  • 2.2. Competitive Insights

3. Perinatal Infections Key Market Trends

  • 3.1. Perinatal Infections Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Perinatal Infections Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Perinatal Infections Market Opportunities
  • 3.4. Perinatal Infections Market Future Trends

4. Perinatal Infections Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Perinatal Infections Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Perinatal Infections Market Landscape

  • 6.1. Perinatal Infections Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Perinatal Infections Market - By Infection

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Infection, 2023 & 2032 (%)
    • 7.1.2. Cytomegalovirus Infection
    • 7.1.3. Enterovirus Infection
    • 7.1.4. Genital Herpes
    • 7.1.5. Gonorrhoea
    • 7.1.6. Human Immunodeficiency Virus
    • 7.1.7. Others

8. Perinatal Infections Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 8.1.2. Maternal Test
    • 8.1.3. Neonatal Test
    • 8.1.4. Others

9. Perinatal Infections Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 9.1.2. Antibiotics
    • 9.1.3. Antiviral
    • 9.1.4. Antiretroviral
    • 9.1.5. Others

10. Perinatal Infections Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 10.1.2. Oral
    • 10.1.3. Parenteral
    • 10.1.4. Others

11. Perinatal Infections Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Homecare
    • 11.1.4. Specialty Clinics
    • 11.1.5. Others

12. Perinatal Infections Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Perinatal Infections Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Perinatal Infections Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Perinatal Infections Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Perinatal Infections Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Perinatal Infections Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Perinatal Infections Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Merck KgaA
    • 13.2.2. Beckman Coulter Inc.
    • 13.2.3. BIOMERIEUX
    • 13.2.4. Bio-Rad Laboratories, Inc
    • 13.2.5. Danaher
    • 13.2.6. Hologic Inc.
    • 13.2.7. Gilead Sciences, Inc.
    • 13.2.8. Emcure Pharmaceuticals Limited.
    • 13.2.9. Cipla Inc.
    • 13.2.10. Hetero
    • 13.2.11. Bausch Health Companies Inc.
    • 13.2.12. Johnson & Johnson Private Limited
    • 13.2.13. Mylan N.V.
    • 13.2.14. Teva Pharmaceutical Industries Ltd.
    • 13.2.15. Sanofi
    • 13.2.16. Novartis AG
    • 13.2.17. Sun Pharmaceutical Industries Ltd
    • 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us